home / stock / mrvl:cc / mrvl:cc quote
Last: | $0.105 |
---|---|
Change Percent: | 0.0% |
Open: | $0.105 |
Close: | $0.105 |
High: | $0.105 |
Low: | $0.105 |
Volume: | 21,320 |
Last Trade Date Time: | 05/05/2022 04:56:13 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.105 | $0.105 | $0.105 | $0.105 | $0.105 | 21,320 | 05-05-2022 |
$0.105 | $0.105 | $0.105 | $0.105 | $0.105 | 38,321 | 05-04-2022 |
$0.1 | $0.11 | $0.1 | $0.11 | $0.1 | 35,860 | 05-03-2022 |
$0.135 | $0.135 | $0.135 | $0.135 | $0.135 | 2,000 | 04-29-2022 |
$0.135 | $0.135 | $0.135 | $0.135 | $0.135 | 2,001 | 04-26-2022 |
$0.12 | $0.14 | $0.12 | $0.14 | $0.12 | 7,000 | 04-25-2022 |
$0.12 | $0.135 | $0.12 | $0.135 | $0.12 | 12,530 | 04-21-2022 |
$0.145 | $0.145 | $0.145 | $0.145 | $0.145 | 3,041 | 04-20-2022 |
$0.145 | $0.145 | $0.145 | $0.145 | $0.145 | 6,500 | 04-19-2022 |
$0.145 | $0.145 | $0.145 | $0.145 | $0.145 | 1,901 | 04-18-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 3,509 | 04-15-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 3,509 | 04-14-2022 |
$0.16 | $0.15 | $0.16 | $0.16 | $0.15 | 13,650 | 04-12-2022 |
$0.15 | $0.15 | $0.15 | $0.15 | $0.15 | 3,900 | 04-08-2022 |
$0.15 | $0.12 | $0.15 | $0.15 | $0.12 | 46,118 | 04-07-2022 |
$0.15 | $0.15 | $0.15 | $0.15 | $0.15 | 3,000 | 04-05-2022 |
$0.165 | $0.14 | $0.165 | $0.165 | $0.14 | 32,500 | 04-01-2022 |
$0.15 | $0.13 | $0.15 | $0.15 | $0.13 | 5,294 | 03-29-2022 |
$0.125 | $0.125 | $0.125 | $0.125 | $0.125 | 61,004 | 03-28-2022 |
$0.125 | $0.125 | $0.125 | $0.125 | $0.125 | 25,530 | 03-25-2022 |
News, Short Squeeze, Breakout and More Instantly...
Marvel Biosciences Corp. Company Name:
MRVL:CC Stock Symbol:
TSXVC Market:
Marvel Biosciences Corp. Website:
Calgary, Alberta--(Newsfile Corp. - June 21, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the " Company " or " Marvel "), wishes to announce that, further to Marvel's May 16, 2024 press release announcing the Company's no...
Calgary, Alberta--(Newsfile Corp. - May 16, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the " Company " or " Marvel "), is pleased to announce a proposed non-brokered private placement of up to 10,000,000 units (the " Un...
Calgary, Alberta--(Newsfile Corp. - March 25, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) , and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel") , today reported promising interim results from its acute study on MB-204 conducted by...